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Rat brain protein kinase C purified to apparent homogeneity [(1986) Biochem. Biophys. Res. Commun. 
135, 6366431 was resolved into three distinct fractions, type I, II and III, upon chromatography on a hy- 
droxyapatite column connected to high-performance liquid chromatography. Comparison of each fraction 
with the four subspecies of protein kinase C, that were separately expressed in COS cells transfected by 
the respective cDNAs, a, /II, j3II an d y, identified the primary structures of these three fractions of protein 
kinase C. Type I corresponded to the enzyme encoded by the y-sequence; type II was a mixture of the two 
subspecies determined by the /?I- and /JR-sequences; and type III had the structure encoded by the a-se- 
quence. The structures and properties of these subspecies of protein kinase C were similar to each other. 
Protein kinase C; cDNA; (COS cell) 
1. INTRODUCTION 
Protein kinase C is now generally accepted as 
playing crucial roles in cell surface signal transduc- 
tion [I]. The enzyme was thought to be a single en- 
tity, but recent analysis of its cDNA clones 
indicates that in the mammalian brain there are 
multiple subspecies of this enzyme with closely 
related structures [2-91. Comparison of their 
predicted amino acid sequences reveals that at least 
four subspecies of protein kinase C may exist in 
this tissue. Since the sequence analysis has been 
carried out independently in several laboratories 
[2-91, different nomenclatures have been pro- 
posed for the various cDNA clones as given in 
table 1. The three cDNA clones, cy, fl and y, ob- 
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tained from the bovine and human brain libraries 
by Coussens et al. [3] are shown to be encoded by 
distinct chromosomes, whereas the two cDNA 
clones, type I and II, obtained from the rat brain 
library are derived from alternative splicing and 
differ from each other in the carboxyl-terminal 
region of only about 50 amino acid residues as 
described earlier 151. Thus, the nomenclature of LY, 
PI, ,811 and y will be used hereafter for the four 
cDNA clones having very similar but different 
nucleotide sequences (table 1). An apparently 
homogeneous preparation of rat brain protein 
kinase C, on the other hand, is shown to be resolv- 
ed further into three fractions, type I, II and III, 
upon chromatography on a hydroxyapatite col- 
umn [ 10,111. The fraction of type II is a mixture of 
the two subspecies of protein kinase C encoded by 
PI- and PII-sequences [ll]. Extending these 
studies, we wish to describe briefly here the iden- 
tification of the structures of type I and type III by 
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Table 1 
cDNA clones of protein kinase C 












type I type II - 4s 
(671) (673) 
_ PKC III PKC II PKC I 6 
(?) (673) (697) 
- RP41 - _ 7b 
(?) 
(6;2) (6:l) (673) 
- 9 
Nomenclature used here 
for cDNA clones cy PI Pll Y 
Subfractions of brain 
enzymes type III type II type I 
a Analysis of partial amino acid sequence of the fragments of protein kinase C predicted 
the existence of this clone 
b A cDNA clone designated as RP16, which apparently differs from all of the cDNA 
clones described above, was also reported 
Numbers in parentheses indicate the length of deduced amino acid sequences of each clone 
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comparison with the subspecies expressed in COS 
cells transfected by each of the rat brain cDNA 
clones, LY, PI, @II and y. 
2. MATERIALS AND METHODS 
2.1. Assay of protein kinase C 
The enzyme was assayed by measuring the incor- 
poration of 32Pi into calf thymus Hi histone from 
[y-32P]ATP in the presence of 8 pg/ml phosphati- 
dylserine, 0.8pg/ml diolein, and 0.5 mM Ca2+ 
under the conditions specified in [12]. Basal 
activity was measured in the presence of 0.5 mM 
EGTA instead of phosphatidylserine, diolein and 
Ca’+. 
2.2. Isolation of a, ,&I, ,&II and y cDNA clones 
Phage cDNA library was constructed using rat 
brain poly(A)+ RNA with AgtlO vector system, and 
PI and PI1 cDNA clones were isolated as in [5]. 
Both LY and y cDNA clones of rat brain protein 
kinase C were obtained by sequential plaque 
screening according to Maniatis et al. [13] using 
synthetic 26-base oligonucleotide probes, which 
corresponded to amino acid residues from 162 to 
170 and 334 to 342 of bovine cr cDNA [3], and 
those from 165 to 173 and 338 to 346 of rat y 
cDNA [6], respectively. Although cDNA clones 
encoding the a type of bovine, human, and rabbit 
protein kinase C were isolated [2,9], the clone of 
this type has not yet been obtained from the rat 
tissue library. Using the oligonucleotide probes for 
the LY type, a cDNA clone containing a 3.2 kb in- 
sert was obtained. This clone, designatedhCKRa5, 
encodes the whole coding sequences of 672 amino 
acids together with the 5 ’ - and 3 ’ -noncoding 
regions, The coding sequence was very similar to 
the a cDNA clones of bovine and rabbit brain 
[2,9]. The y cDNA clone designated ACKRyl of 
3.1 kb includes the full coding sequence with non- 
coding regions on both sides. The nucleotide se- 
quence of this clone was identical with that of PKC 
I described by Knopf et al. [6]. The detailed pro- 
cedures of isolation and the precise comparison of 
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the nucleotide sequences of rat LY, PI and pII and 
y cDNAs will be described elsewhere. 
2.3. Construction of expression plasmids 20 
The expression plasmid was constructed from 
Okayama and Berg vectors [14], which was essen- 
tially similar to pcDL1 reported by Ebina et al. 
[ 151. The EcoRI-EcoRI cDNA fragment of 
isolated clones was inserted into the EcoRI site of 
the expression plasmid as described [l 11. 
2.4. Expression in COS cells 
Fresh monolayers of COS 7 cells with Dulbec- 
co’s modified Eagle medium containing 5% fetal 
calf serum were transfected with the plasmid DNA 
using the calcium phosphate co-precipitation 
technique [16,17]. 
3. RESULTS AND DISCUSSION 
3.1. Resolution of protein kinase C into three 
fractions 
Protein kinase C was purified from the cytosol 
of rat brain by DE-52 (Whatman), threonine- 
Sepharose, and TSK phenyl-SPW (Toy0 Soda) col- 
umn chromatographies as described previously 
[12]. This enzyme was resolved further into three 
distinct fractions upon chromatography on a 
hydroxyapatite column connected to high- 
performance liquid chromatography, Pharmacia 
FPLC system. The TSK phenyl-5PW fraction of 
protein kinase C was diluted with an equal volume 
of 20 mM potassium phosphate buffer at pH 7.5, 
containing 0.5 mM EGTA, 0.5 mM EDTA, 10% 
glycerol, and 10 mM 2-mercaptoethanol (buffer 
A), and was applied to a packed hydroxyapatite 
column (0.78 x 10 cm, Koken, Tokyo, type S) 
equilibrated with buffer A. Protein kinase C was 
then eluted by application of a linear concentration 
gradient of potassium phosphate buffer at pH 7.5 
(20-250 mM) in 84 ml buffer A. Fractions of 1 ml 
each were collected. All procedures were carried 
out at 0-4°C. Three distinct fractions of protein 
kinase C were obtained; type I (fractions 24-28), 
type II (fractions 31-39), and type III (fractions 
50-57) as shown in fig.lA. The three enzyme frac- 
tions did not appear to be simple artifacts during 
the purification procedures, and the elution profile 
was highly reproducible. Proteolytic modification 
may presumably be excluded, since the extraction 
Fig. 1. Hydroxyapatite column chromatography of 
several subspecies of protein kinase C. A purified 
preparation of rat brain protein kinase C and the 
enzymes newly expressed in the COS 7 cells were applied 
to hydroxyapatite column chromatography, and 
enzymatic activity was assayed as described in section 2. 
(A) Rat brain protein kinase C; (B-D) protein kinase C 
from the COS 7 cells transfected with (Y, ,611, and 7 
cDNA, respectively; (E) protein kinase C from 
untransfected control COS 7 cells. (o---o) Protein 
kinase activity in the presence of phosphatidylserine, 
diolein, and CaC12; (C--O) protein kinase activity in 
the presence of EGTA instead of phosphatidylserine, 
diolein, and CaC12; (-) potassium phosphate. 
buffer contained high concentrations of both 
EGTA and EDTA to remove Ca’+. The enzymes in 
these fractions each showed a single band with 
roughly an identical molecular mass of 80 kDa 
upon SDS-polyacrylamide gel electrophoresis. The 
three enzymes reacted equally with a monoclonal 
20 40 60 
FRACTION NUMBER 
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antibody raised to a common polypeptide sequence 
present in the four subspecies of protein kinase C. 
Type III enzyme normally appeared as a broad 
peak, and heterogeneity of this enzyme fraction is 
unknown at present. 
3.2. Expression of four subspecies of protein 
kinase C 
The cDNAs encoding my, PI and ,&I1 and y 
subspecies of protein kinase C were each inserted 
in the expression plasmid, and transfected 
separately to COS 7 cells as described in section 2. 
The enzymes expressed in the COS 7 cells were par- 
tially purified under the conditions described 
below. The COS 7 cells were homogenized by 
sonication in 20 mM Tris-HCI at pH 7.5, contain- 
ing 0.25 M sucrose, 10 mM EGTA, 2 mM EDTA 
and 20 /rg/ml leupeptin. The homogenate was cen- 
trifuged for 60 min at 100000 x g. The superna- 
tant was diluted with 6 vols of 20 mM Tris-HCl at 
pH 7.5, containing 0.5 mM EGTA, 0.5 mM 
EDTA and 10 mM 2-mercaptoethanol (buffer B), 
and was applied to a Mono Q column (1 x 10 cm, 
Pharmacia HR lO/lO) equilibrated with buffer B. 
The enzyme was eluted by application of a linear 
concentration gradient of NaCl (O-O.6 M) in 
164 ml buffer B. Fractions of 4 ml each were col- 
lected, and the fractions possessing protein kinase 
C activity were pooled and subjected to hydrox- 
yapatite column chromatography as described 
above. The activity of protein kinase C from the 
COS 7 cells transfected by each cDNA was usually 
3-IO-times higher than that of the control cells. 
When equivalent amounts of the enzyme from the 
Mono Q column was subjected to hydroxyapatite 
column chromatography, several different pat- 
terns of the enzyme were obtained as shown in 
fig.lB-D. The COS 7 cells transfected with the 
plasmid containing LY cDNA showed one major 
peak (fractions 47-60) (fig.lB), whereas the con- 
trol enzyme preparation from untransfected COS 7 
cells showed only a minor, broad peak at the same 
position (fig.lE). Fig.lC shows the enzyme pattern 
obtained from the ,&I1 cDNA-transfected cells. A 
new major peak appeared (fractions 29-38) that 
eluted at the position corresponding to type II pro- 
tein kinase C. A similar result was obtained for the 
COS 7 cells transfected by PI cDNA, and both PI 
and pII enzymes expressed in COS 7 cells were in- 
distinguishable from one another. In contrast, 
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when COS 7 cells were transfected with the 
plasmid containing y cDNA, another new peak of 
protein kinase appeared which eluted at the posi- 
tion corresponding to the type I enzyme (fractions 
24-30) (fig.lD). All protein kinases thus obtained 
showed typical characteristics of protein kinase C, 
being dependent on the simultaneous presence of 
Ca2+, phospholipid, and diacylglycerol for full en- 
zymatic activity. The results presented above 
together with those described in a preceding report 
[l l] indicate that the three types of protein kinase 
C isolated from the rat brain cytosol, type I, II and 
III, closely resemble the structures of y, PI and PI1 
and a-sequences, respectively, that have been 
predicted by analysis of the cDNA clones. 
However, the possibility may not be excluded that 
additional species of protein kinase C exist in these 
three fractions that are separated by hydrox- 
yapatite column chromatography. There may also 
be some posttranslational modification of the en- 
zyme, since the amino-terminal of the enzyme is 
not detected by Edman degradation. The amino 
acid sequence analysis of each species of protein 
kinase C is needed to establish the exact relation- 
ship between the gene and protein molecule. More 
details of the properties and comparison of these 
different fractions of protein kinase C will be 
described elsewhere. 
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